Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Lantheus Stock Is Soaring Today

TheMotleyFool

0 0

Why Lantheus Stock Is Soaring TodayPhoto, wide shot, wide-angle lens, Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png

Shares of Lantheus Holdings (NASDAQ: LNTH) were soaring 17.1% as of 11:01 a.m. EDT on Thursday. The big jump came after the company announced that the Food and Drug Administration had approved Pylarify, an imaging agent used to identify prostate cancer.

Today's significant gain for the life sciences stock underscores how optimistic investors are about the market potential for Pylarify. It's the first imaging agent to win FDA approval that's targeted to the prostate-specific membrane antigen (PSMA) for use in positron emission tomography.

Image source: Getty Images.

Source Fool.com

Like: 0

LNTH

Teilen